134 results on '"AUGELLO, Giuseppa"'
Search Results
2. The potential of the nutraceutical berberine in the treatment of hepatocellular carcinoma and other liver diseases such as NAFLD and NASH
3. Extracellular Vesicle-Related Non-Coding RNAs in Hepatocellular Carcinoma: An Overview.
4. Genetic Biomarkers of Sorafenib Response in Patients with Hepatocellular Carcinoma.
5. Genetic biomarkers of sorafenib response in patients with hepatocellular carcinoma
6. Genetic biomarkers for sorafenib response in patients with hepatocellular carcinoma
7. New Insights into the Behavior of NHC-Gold Complexes in Cancer Cells
8. Lipid nanocarriers containing sorafenib inhibit colonies formation in human hepatocarcinoma cells
9. The clinical impact of an extra virgin olive oil enriched mediterranean diet on metabolic syndrome: Lights and shadows of a nutraceutical approach
10. Outcome predictors in SARS-CoV-2 disease (COVID-19): The prominent role of IL-6 levels and an IL-6 gene polymorphism in a western Sicilian population
11. Preclinical evaluation of antitumor activity of the proteasome inhibitor MLN2238 (ixazomib) in hepatocellular carcinoma cells
12. Effects of TP53 Mutations and miRs on Immune Responses in the Tumor Microenvironment Important in Pancreatic Cancer Progression
13. miR-126-3p and miR-21-5p as Hallmarks of Bio-Positive Ageing; Correlation Analysis and Machine Learning Prediction in Young to Ultra-Centenarian Sicilian Population
14. The NUPR1/p73 axis contributes to sorafenib resistance in hepatocellular carcinoma
15. NUPR1 protects liver from lipotoxic injury by improving the endoplasmic reticulum stress response
16. Can Be miR-126-3p a Biomarker of Premature Aging? An Ex Vivo and In Vitro Study in Fabry Disease
17. SAT-288 - Genetic biomarkers for sorafenib response in patients with hepatocellular carcinoma
18. Potential Uses of Olive Oil Secoiridoids for the Prevention and Treatment of Cancer: A Narrative Review of Preclinical Studies
19. Hepatocellular Carcinoma: A Difficult Cancer to Treat
20. Hepatic and circulating levels of PCSK9 in morbidly obese patients: Relation with severity of liver steatosis
21. NUPR1 protects liver from lipotoxic injury by improving the endoplasmic reticulum stress response
22. GSK-3 in liver diseases: Friend or foe?
23. The Role of GSK-3 in Cancer Immunotherapy: GSK-3 Inhibitors as a New Frontier in Cancer Treatment
24. The Prevalence of NAFLD and Fibrosis in Bariatric Surgery Patients and the Reliability of Noninvasive Diagnostic Methods
25. Identification of an LPS-Induced Chemo-Attractive Peptide from Ciona robusta
26. New landscapes and horizons in hepatocellular carcinoma therapy
27. RAS/RAF/MEK/ERK, PI3K/PTEN/AKT/mTORC1 and TP53 pathways and regulatory miRs as therapeutic targets in hepatocellular carcinoma
28. Targeting HSP90 with the small molecule inhibitor AUY922 (luminespib) as a treatment strategy against hepatocellular carcinoma
29. Cationic Solid Lipid Nanoparticles as Non Viral Vectors for the Inhibition of Hepatocellular Carcinoma Growth by RNA Interference
30. Association Between MICA Gene Variants and the Risk of Hepatitis C Virus-Induced Hepatocellular Cancer in a Sicilian Population Sample
31. Cationic Solid Lipid Nanoparticles (SLN) for shNupr1 plasmid delivery in the treatment of hepatocellular carcinoma (HCC)
32. Cytokine profile of breast cell lines after different radiation doses
33. Pivotal roles of glycogen synthase-3 in hepatocellular carcinoma
34. Oleocanthal exerts antitumor effects on human liver and colon cancer cells through ROS generation
35. Biocompatible Lipid Nanoparticles as Carriers To Improve Curcumin Efficacy in Ovarian Cancer Treatment
36. Delivery of shNupr1 plasmid by solid lipid nanoparticles reduces the expression of Nupr1 gene in hepatocellular carcinoma cells
37. Cationic solid lipid nanoparticles complexed with genetic material for liver tumor treatment
38. Delivery of shRNA plasmid DNA by cationic solid lipid nanoparticles for gene silencing in human hepatocarcinoma cells
39. Targeting HSP90 with the small molecule inhibitor AUY922 (luminespib) as a treatment strategy against hepatocellular carcinoma.
40. A PTEN inhibitor displays preclinical activity against hepatocarcinoma cells
41. Association Between <italic>MICA</italic> Gene Variants and the Risk of Hepatitis C Virus-Induced Hepatocellular Cancer in a Sicilian Population Sample.
42. PROLONGED TREATMENT OF HUMAN OSTEOSARCOMA MG63 CELLS WITH 3AB INDUCES THE PRODUCTION OF TUMOR INITIATING CELLS
43. Western Blotting Analysis
44. Electrophoretic Mobility Shift Assay (EMSA) or Gel Shift Assay
45. In Human Retinoblastoma Y-79 Cells 3-aminobenzamide induces Differentiation
46. From Targets to Targeted Therapies in Hepatocellular Carcinoma
47. In human retinoblastoma Y79 cells okadaic acid–parthenolide co-treatment induces synergistic apoptotic effects, with PTEN as a key player
48. Paclitaxel and beta-lapachone synergistically induce apoptosis in human retinoblastoma Y79 cells by downregulating the levels of phospho-Akt
49. NUPR1 protects liver from lipotoxic injury by improving the endoplasmic reticulum stress response.
50. Outcome predictors in SARS-CoV-2 disease (COVID-19): The prominent role of IL-6 levels and an IL-6 gene polymorphism in a western Sicilian population
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.